AU2502301A - Medicament and combination of compatible medicaments - Google Patents

Medicament and combination of compatible medicaments

Info

Publication number
AU2502301A
AU2502301A AU25023/01A AU2502301A AU2502301A AU 2502301 A AU2502301 A AU 2502301A AU 25023/01 A AU25023/01 A AU 25023/01A AU 2502301 A AU2502301 A AU 2502301A AU 2502301 A AU2502301 A AU 2502301A
Authority
AU
Australia
Prior art keywords
medicament
combination
medicaments
compatible
compatible medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25023/01A
Inventor
Wolf Bertling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
November AG Novus Medicatus Bertling Gesellschaft fuer Molekular Medizin
Original Assignee
November AG Novus Medicatus Bertling Gesellschaft fuer Molekular Medizin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929548&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2502301(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by November AG Novus Medicatus Bertling Gesellschaft fuer Molekular Medizin filed Critical November AG Novus Medicatus Bertling Gesellschaft fuer Molekular Medizin
Publication of AU2502301A publication Critical patent/AU2502301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

The invention relates to a medicament or a combination of compatible medicaments for combined administration. Said medicament or combination of medicaments contains at least one active agent and at least one antagonist of said active agent.
AU25023/01A 1999-11-19 2000-11-16 Medicament and combination of compatible medicaments Abandoned AU2502301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19955607 1999-11-19
DE19955607A DE19955607A1 (en) 1999-11-19 1999-11-19 Drug or coordinated combination of drugs
PCT/DE2000/003977 WO2001037818A2 (en) 1999-11-19 2000-11-16 Medicament and combination of compatible medicaments

Publications (1)

Publication Number Publication Date
AU2502301A true AU2502301A (en) 2001-06-04

Family

ID=7929548

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25023/01A Abandoned AU2502301A (en) 1999-11-19 2000-11-16 Medicament and combination of compatible medicaments

Country Status (7)

Country Link
EP (1) EP1235569B1 (en)
JP (1) JP2003514849A (en)
AT (1) ATE259229T1 (en)
AU (1) AU2502301A (en)
CA (1) CA2388103A1 (en)
DE (2) DE19955607A1 (en)
WO (1) WO2001037818A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286070T3 (en) 2000-05-12 2007-12-01 Nattopharma Asa FOOD PRODUCT CONTAINING VITAMIN K2.
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
WO2008082542A1 (en) * 2006-12-19 2008-07-10 Institute For Therapeutic Research, Inc. Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
SE533680C2 (en) * 2009-04-07 2010-11-30 Per Ola Andersson Method and apparatus for detecting drugs in a sample

Also Published As

Publication number Publication date
DE50005282D1 (en) 2004-03-18
JP2003514849A (en) 2003-04-22
EP1235569B1 (en) 2004-02-11
EP1235569A2 (en) 2002-09-04
ATE259229T1 (en) 2004-02-15
CA2388103A1 (en) 2001-05-31
WO2001037818A2 (en) 2001-05-31
WO2001037818A3 (en) 2002-06-20
DE19955607A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
AU2274201A (en) Compounds and compositions for delivering active agents
WO2000007979A3 (en) Compounds and compositions for delivering active agents
BG106030A (en) Pharmaceutical composition
MXPA01008611A (en) Compounds and compositions for delivering active agents.
CA2294783A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AU2513900A (en) Drug dosage unit for buccal administration of steroidal active agents
HK1054918A1 (en) Compounds and compositions for delivering active agents
BR0015188A (en) Pharmaceutical compositions
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
CA2360220A1 (en) Oxadiazole compounds and compositions for delivering active agents
WO2000003753A3 (en) Microdisperse drug delivery systems
EP2308479A3 (en) Compounds and compositions for delivering active agents
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator
AU2003290015A1 (en) Mastitis treatment
AU2502301A (en) Medicament and combination of compatible medicaments
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
GEP20043377B (en) Pharmaceutical Complex
MXPA01008348A (en) Microcapsules for sustained release of drugs.
AU1584800A (en) Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
WO2001091733A3 (en) Combination of active substances containing montirelin and a compound having an opioid effect

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase